An Asian multi-regional registry study of rare cancers: The MASTER KEY ASIA and MASTER KEY Japan projects.

被引：0
|
作者：
Okuma, Hitomi Sumiyoshi
Yonemori, Kan
Ishioka, Chikashi
Baba, Eishi
Kinoshita, Ichiro
Muto, Manabu
Imasa, Marcelo Severino Bulauitan
Voon, Pei Jye
de Almeida, Kathleen Yasmin
Hoo, Hwoei Fen Soo
Ichimura, Masahiko
Mizoguchi, Chiharu
Munakata, Wataru
Kohsaka, Shinji
Shibata, Taro
Yatabe, Yasushi
Nakamura, Kenichi
Mano, Hiroyuki
Yamamoto, Noboru
机构：
[1] Natl Canc Ctr, Dept Int Clin Dev, Tokyo, Japan
[2] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[3] Tohoku Univ Hosp, Aoba Ku, Sendai, Miyagi, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Oncol & Social Med, Fukuoka, Japan
[5] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
[6] Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan
[7] St Lukes Med Ctr, Inst Canc, Quezon City, Philippines
[8] Hosp Umum Sarawak, Sarawak, Malaysia
[9] Natl Canc Ctr, Tokyo, Japan
[10] Penang Hosp, Dept Radiotherapy & Oncol, George Town, Penang, Malaysia
[11] Natl Canc Ctr, Div Cellular Signaling, Tokyo, Japan
[12] Natl Canc Ctr, Tokyo, Japan
[13] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15052
引用
收藏
页数：1
相关论文
共 13 条
  • [1] MASTER KEY Project Japan and MASTER KEY Asia; an Asian platform for rare cancers
    Okuma, Hitomi
    ANNALS OF ONCOLOGY, 2023, 34 : S1365 - S1365
  • [2] MASTER KEY Project: A platform study for rare cancers in Japan and Asia
    Okuma, Hitomi
    ANNALS OF ONCOLOGY, 2022, 33 : S448 - S448
  • [3] A platform trial with a registry study for rare cancers: MASTER KEY project
    Narita, S. N.
    Okuma, H. S.
    Yonemori, K.
    Sukigara, T.
    Hirakawa, A.
    Munakata, W.
    Okita, N.
    Shimizu, T.
    Shibata, T.
    Kawai, A.
    Yamamoto, N.
    Izutsu, K.
    Muto, M.
    Akita, H.
    Baba, E.
    Nakamura, K.
    Mano, H.
    Nishida, T.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] MASTER KEY project: A basket/umbrella trial for rare cancers in Japan
    Noda, S.
    Yonemori, K.
    Shirakawa, N.
    Okuma, H. S.
    Shimizu, T.
    Hirakawa, A.
    Shibata, T.
    Sukigara, T.
    Okita, N.
    Kawai, A.
    Yamamoto, N.
    Nakamura, K.
    Mano, H.
    Nishida, T.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 148 - 148
  • [5] MASTER KEY project: A basket/umbrella trial for rare cancers in Japan.
    Okuma, Hitomi Sumiyoshi
    Yonemori, Kan
    Shimizu, Toshio
    Goto, Yasushi
    Honma, Yoshitaka
    Morizane, Chigusa
    Noguchi, Emi
    Sudo, Kazuki
    Munakata, Wataru
    Sunami, Kuniko
    Hiraoka, Nobuyoshi
    Kohno, Takashi
    Hirakawa, Akihiro
    Shibata, Taro
    Sukigara, Tamie
    Kawai, Akira
    Yamamoto, Noboru
    Nakamura, Kenichi
    Nishida, Toshirou
    Fujiwara, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Clinical landscape of precision oncology for rare cancers among diverse Asian populations: Insights from the MASTER KEY registry.
    Mizoguchi, Chiharu
    Okuma, Hitomi Sumiyoshi
    Muto, Manabu
    Kinoshita, Ichiro
    Baba, Eishi
    Takahashi, Masanobu
    Ando, Masashi
    Hoo, Hwoei Fen Soo
    Yusak, Suhana
    Voon, Pei Jye
    Ramachandran, Rangasamy
    Thiagarajan, Muthukkumaran
    Imasa, Marcelo Severino Bulauitan
    Malik, Rozita Abdul
    Choi, Wonyoung
    Van Dao, Tu
    Chen, Tom Wei-Wu
    Yonemori, Kan
    Nakamura, Kenichi
    Yamamoto, Noboru
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Clnical development infrastructure for Rare Cancers, MASTER KEY PROJECT
    Yonemori, Kan
    CANCER SCIENCE, 2024, 115 : 1727 - 1727
  • [8] Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project
    Okuma, Hitomi S.
    Fujiwara, Yasuhiro
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 491 - 492
  • [9] Response to "Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project"
    Yamashita, Kenji
    Kaneko, Masayuki
    Narukawa, Mamoru
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 493 - 493
  • [10] MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
    Okuma, Hitomi S.
    Yonemori, Kan
    Narita, Shoko N.
    Sukigara, Tamie
    Hirakawa, Akihiro
    Shimizu, Toshio
    Shibata, Taro
    Kawai, Akira
    Yamamoto, Noboru
    Nakamura, Kenichi
    Nishida, Toshiro
    Fujiwara, Yasuhiro
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 596 - 605
12